Original Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Cardiol. Nov 26, 2011; 3(11): 359-366
Published online Nov 26, 2011. doi: 10.4330/wjc.v3.i11.359
Table 1 Patient demographics n (%)
All patients (n = 273)LES < 15 (n = 193)LES15 (n = 80)P value
Gender (male)128 (47)90 (47)38 (48)0.900
Age (mean ± SD, yr)82.7 ± 2.3582.4 ± 2.2183.5 ± 2.53< 0.001
Surgery
AVR140 (51)103 (53)37 (46)0.280
AVR with CABG133 (49)90 (47)43 (54)
Previous MI
None231 (85)180 (93)51 (64)< 0.001
≤ 90 d26 (10)6 (3)20 (25)
> 90 d16 (6)7 (4)9 (11)
Diabetes mellitus30 (11)27 (14)3 (4)0.014
Renal impairment11 (4)4 (2)7 (9)0.011
Previous PCI4 (2)04 (5)0.002
Pulmonary disease47 (17)21 (11)26 (33)< 0.001
Prior cardiac surgery13 (5)1 (1)12 (15)< 0.001
CVA/TIA42 (15)28 (15)14 (18)0.450
PVD25 (9)12 (6)13 (16)0.009
CAD
None135 (50)100 (52)35 (44)0.590
1 vessel disease46 (17)33 (17)13 (16)
2 vessel disease42 (15)28 (15)14 (18)
3 vessel disease49 (18)31 (16)18 (23)
Pathology
AS239 (88)170 (88)69 (86)0.680
AS with mild AR34 (12)23 (12)11 (14)
Valve
Mechanical15 (6)13 (7)2 (3)0.160
Biological258 (95)180 (93)78 (98)
Cardiogenic shock4 (2)04 (5)0.002
Ejection fraction
< 30%15 (6)015 (19)< 0.001
30%-49%62 (23)37 (19)25 (31)
50% and above196 (72)156 (81)40 (50)
EuroSCORE, median (IQR)9 (8-10)8 (8-9)11 (10-12)
LES, median (IQR)11.1 (8.4-16.6)9.5 (7.9-11.6)20.7 (17.4-24.9)
Table 2 Perioperative and postoperative outcomes n (%)
All patients (n = 273)LES < 15 (n = 193)LES15 (n = 80)Effect (95% CI)P value
Stroke13 (5)8 (4)5 (6)OR 1.54 (0.49-4.86)0.460
MI3 (1)3 (2)0
Cardiac tamponade14 (5)7 (4)7 (9)OR 2.55 (0.86.7.52)0.090
Gastrointestinal bleeding11 (4)8 (4)3 (4)OR 0.90 (0.23-3.49)0.880
Infection22 (8)15 (8)7 (9)OR 1.14 (0.45-2.91)0.790
Renal impairment44 (16)26 (14)18 (23)OR 1.86 (0.96-3.64)0.070
PPM insertion23 (8)14 (7)9 (11)OR 1.60 (0.66-3.87)0.290
Mortality
30 d19 (7)8 (4)11 (14)OR 3.69 (1.42-9.55)0.007
≤ 90 d31 (11)16 (8)15 (19)OR 2.55 (1.19-5.46)
> 90 d22 (8)10 (5)12 (15)0.020
Discharge
Home153 (56)118 (61)35 (44)
Other hospital or Ward97 (36)64 (33)33 (41)
Survival (yr), median (IQR)6.22 (3.00-10.94)8.74 (3.54-11.07)4.19 (1.83-5.94)HR 2.12 (1.40-3.22 )< 0.001
1 yr postop (95% CI)87% (82%-90%)90% (85%-94%)79% (68%-86%)
5 yr postop (95% CI)57% (49%-64%)64% (54%-72%)40% (26%-55%)
ICU stay
Median (IQR)1 (1-3)1 (1-3)2 (1-3)HR 0.86 (0.66-1.14)0.290
Death pre ICU6 (2)2 (1)4 (5)
HDU stay
Median (IQR)3 (1-4)2 (1-4)4 (2-5)HR 0.67 (0.50-0.89)0.006
Death pre HDU13 (5)5 (3)8 (10)
Ward stay
Median (IQR)6 (4-9)6 (4-9)5 (4-8)HR 1.16 (0.87-1.55)0.310
Death pre ICU17 (6)7 (4)10 (13)
Overall, median (IQR)11 (8-15)11 (8-15)11 (8-15)HR 0.89 (0.67-1.17)0.400